176 related articles for article (PubMed ID: 31233196)
1. Downregulation of PDCD4 induced by progesterone is mediated by the PI3K/AKT signaling pathway in human endometrial cancer cells.
Wang X; Li Y; Wan L; Liu Y; Sun Y; Liu Y; Shi Y; Zhang L; Zhou H; Wang J; Wang X; Wei Z
Oncol Rep; 2019 Aug; 42(2):849-856. PubMed ID: 31233196
[TBL] [Abstract][Full Text] [Related]
2. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
3. Control of a tumor suppressor PDCD4: Degradation mechanisms of the protein in hepatocellular carcinoma cells.
Matsuhashi S; Hamajima H; Xia J; Zhang H; Mizuta T; Anzai K; Ozaki I
Cell Signal; 2014 Mar; 26(3):603-10. PubMed ID: 24334270
[TBL] [Abstract][Full Text] [Related]
4. miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells.
Zhuo Z; Yu H
Oncotarget; 2017 Apr; 8(17):28042-28051. PubMed ID: 28427207
[TBL] [Abstract][Full Text] [Related]
5. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
Sun Y; Wang C; Yang H; Ma X
Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
[TBL] [Abstract][Full Text] [Related]
6. PLEKHA5 regulates tumor growth in metastatic melanoma.
Zhang H; Zhu H; Deng G; Zito CR; Oria VO; Rane CK; Zhang S; Weiss SA; Tran T; Adeniran A; Zhang F; Zhou J; Kluger Y; Bosenberg MW; Kluger HM; Jilaveanu LB
Cancer; 2020 Mar; 126(5):1016-1030. PubMed ID: 31769872
[TBL] [Abstract][Full Text] [Related]
7. Progress on the relationship between tumor suppressor PDCD4 and diseases based on the analysis of structural characteristics.
Hui L; Guang-Ming W
Yi Chuan; 2024 Apr; 46(4):290-305. PubMed ID: 38632092
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin.
Pant A; Lee II; Lu Z; Rueda BR; Schink J; Kim JJ
PLoS One; 2012; 7(7):e41593. PubMed ID: 22911820
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
[TBL] [Abstract][Full Text] [Related]
10. Tumour suppressive function and modulation of programmed cell death 4 (PDCD4) in ovarian cancer.
Wei N; Liu SS; Chan KK; Ngan HY
PLoS One; 2012; 7(1):e30311. PubMed ID: 22272332
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
12. Regulation of tumor suppressor PDCD4 by novel protein kinase C isoforms.
Nakashima M; Hamajima H; Xia J; Iwane S; Kwaguchi Y; Eguchi Y; Mizuta T; Fujimoto K; Ozaki I; Matsuhashi S
Biochim Biophys Acta; 2010 Sep; 1803(9):1020-7. PubMed ID: 20471435
[TBL] [Abstract][Full Text] [Related]
13. Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway.
Wang WQ; Zhang H; Wang HB; Sun YG; Peng ZH; Zhou G; Yang SM; Wang RQ; Fang DC
Mol Diagn Ther; 2010 Jun; 14(3):155-61. PubMed ID: 20560677
[TBL] [Abstract][Full Text] [Related]
14. Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway.
Huang J; Liu C; Duan S; Lin J; Luo Y; Tao S; Xing S; Zhang X; Du H; Wang H; Huang C; Wei G
Life Sci; 2021 Jun; 274():119354. PubMed ID: 33737087
[TBL] [Abstract][Full Text] [Related]
15. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.
Palamarchuk A; Efanov A; Maximov V; Aqeilan RI; Croce CM; Pekarsky Y
Cancer Res; 2005 Dec; 65(24):11282-6. PubMed ID: 16357133
[TBL] [Abstract][Full Text] [Related]
16. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-induced loss of Pdcd4 is mediated by phosphorylation-dependent degradation.
Schmid T; Bajer MM; Blees JS; Eifler LK; Milke L; Rübsamen D; Schulz K; Weigert A; Baker AR; Colburn NH; Brüne B
Carcinogenesis; 2011 Oct; 32(10):1427-33. PubMed ID: 21771721
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antitumor effect of BRMS1 and sorafenib via inhibition of the PI3K/AKT/mTOR/ERK signaling pathway.
Jin J; Guo Y; Liu Y; Wang Z; Yang X; Sun S
Oncol Rep; 2019 Sep; 42(3):1183-1193. PubMed ID: 31233204
[TBL] [Abstract][Full Text] [Related]
19. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
20. Effects of targeting endometrial stromal sarcoma cells via histone deacetylase and PI3K/AKT/mTOR signaling.
Quan P; Moinfar F; Kufferath I; Absenger M; Kueznik T; Denk H; Zatloukal K; Haybaeck J
Anticancer Res; 2014 Jun; 34(6):2883-97. PubMed ID: 24922651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]